# Mundipharma

Source: https://onco.cc/companies/mundipharma/  
OnCo record `mundipharma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Mundipharma is the privately held network of companies associated with the Sackler family outside the United States, known for opioid pain medicines used in cancer care and, in Europe, for oncology products such as the antifungal and haematology lines it licenses.

## Summary

Mundipharma comprises independent associated companies, with the German business in Limburg an der Lahn founded in 1967, that market pain medicines including controlled-release oxycodone and buprenorphine, as well as oncology, haematology and anti-infective products in many countries. Its research arm, Mundipharma Research GmbH, has led phase 3 trials in cancer pain and supportive care registered on ClinicalTrials.gov.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Mundipharma Research GmbH & Co KG; Mundipharma Research; Mundipharma International; Napp Pharmaceuticals
- Tags: ctgov-sponsor
- HQ: Limburg an der Lahn
- Type: pharma
- Website: http://www.mundipharma.de

## Sources

- Official website: http://www.mundipharma.de
- ClinicalTrials.gov: trials led by Mundipharma Research GmbH & Co KG: https://clinicaltrials.gov/search?lead=Mundipharma%20Research%20GmbH%20%26%20Co%20KG
- Wikidata: https://www.wikidata.org/wiki/Q1952722

## Connected records

- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/mundipharma.json